BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23242407)

  • 1. Synthetic cannabinoid use in New Zealand: a recent rebound.
    Schep LJ; Slaughter RJ; Temple WA; Lambie BS; Gee P; Watts M; Gresham C
    N Z Med J; 2012 Oct; 125(1364):114-6. PubMed ID: 23242407
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic cannabinoid use in New Zealand: a brief evaluation of inquiries to the New Zealand National Poisons Centre.
    Schep LJ; Slaughter RJ; Temple WA
    N Z Med J; 2011 Dec; 124(1347):99-101. PubMed ID: 22237580
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB; Kleinschmidt K; Schwarz E; Young A
    J Addict Dis; 2011 Oct; 30(4):351-8. PubMed ID: 22026527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geographic distribution of synthetic cannabinoid exposures reported to Texas poison centers.
    Forrester MB; Haywood T
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):603-8. PubMed ID: 22571605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and synthetic cannabinoid exposure reported to the Israel poison information center: Examining differences in exposures to medical and recreational compounds.
    Sznitman SR; Pinsky-Talbi L; Salameh M; Moed T; Bentur Y
    Int J Drug Policy; 2020 Mar; 77():102711. PubMed ID: 32126489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak of synthetic cannabinoid exposures reported to a regional poison center: "K2" identified as 5F-ADB.
    Arens AM; Olives TD; Simpson NS; Laes JR; Anderson DL; Bangh SA; Lee SC; Martin S; Banister SD; Gerona RR; Cole JB
    Clin Toxicol (Phila); 2019 Jan; 57(1):69-71. PubMed ID: 30430881
    [No Abstract]   [Full Text] [Related]  

  • 7. An apparent drop in synthetic cannabinoid presentations.
    Mason E
    N Z Med J; 2013 Dec; 126(1387):191. PubMed ID: 24362747
    [No Abstract]   [Full Text] [Related]  

  • 8. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010.
    Hoyte CO; Jacob J; Monte AA; Al-Jumaan M; Bronstein AC; Heard KJ
    Ann Emerg Med; 2012 Oct; 60(4):435-8. PubMed ID: 22575211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic cannabinoid and marijuana exposures reported to poison centers.
    Forrester MB; Kleinschmidt K; Schwarz E; Young A
    Hum Exp Toxicol; 2012 Oct; 31(10):1006-11. PubMed ID: 22859662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Investigation of smokable herbal mixtures abuse based on JPIC inquiries].
    Kuroki Y
    Chudoku Kenkyu; 2011 Dec; 24(4):323-7. PubMed ID: 22338344
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe Illness Associated with Reported Use of Synthetic Cannabinoids - Mississippi, April 2015.
    Kasper AM; Ridpath AD; Arnold JK; Chatham-Stephens K; Morrison M; Olayinka O; Parker C; Galli R; Cox R; Preacely N; Anderson J; Kyle PB; Gerona R; Martin C; Schier J; Wolkin A; Dobbs T
    MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(39):1121-2. PubMed ID: 26447715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notes from the Field: Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use - United States, January-May 2015.
    Law R; Schier J; Martin C; Chang A; Wolkin A;
    MMWR Morb Mortal Wkly Rep; 2015 Jun; 64(22):618-9. PubMed ID: 26068566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of Australian legislative changes on synthetic cannabinoid exposures reported to the New South Wales Poisons Information Centre.
    Cairns R; Brown JA; Gunja N; Buckley NA
    Int J Drug Policy; 2017 May; 43():74-82. PubMed ID: 28343112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Profile of acute poisoning in Italy. Analysis of the data reported by Poison Centres].
    Mucci N; Alessi M; Binetti R; Magliocchi MG
    Ann Ist Super Sanita; 2006; 42(3):268-76. PubMed ID: 17124350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of trends in animal poisoning cases in the United States: 2002-2010.
    McLean MK; Hansen SR
    Vet Clin North Am Small Anim Pract; 2012 Mar; 42(2):219-28, v. PubMed ID: 22381174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Changing Face of Synthetic Cannabinoids in Texas.
    Maxwell JC
    J Psychoactive Drugs; 2018; 50(4):281-286. PubMed ID: 30321129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tasks and importance of the acute poisoning center at a multiprofile provincial hospital based on 10 years experience].
    Lata S; Molczyk A; Madej T
    Przegl Lek; 2005; 62(6):555-7. PubMed ID: 16225122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reflections on the 2011 report of the US National Poison Data System.
    Hendrickson RG; Osterhoudt KC
    Clin Toxicol (Phila); 2012 Dec; 50(10):869-71. PubMed ID: 23216135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes after Kratom exposures: A poison center case series.
    Cumpston KL; Carter M; Wills BK
    Am J Emerg Med; 2018 Jan; 36(1):166-168. PubMed ID: 28751041
    [No Abstract]   [Full Text] [Related]  

  • 20. International Poison Information Center data collection capabilities.
    Krenzelok EP; McElwee NE
    Vet Hum Toxicol; 1995 Jun; 37(3):246-8. PubMed ID: 7571358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.